Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ASCO 2022 | Steps to combat bias and microaggression in healthcare

Narjust Duma • 3 Jun 2022
ASCO 2022
General

Narjust Duma, MD, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, provides an overview of steps can be implemented in clinical practice to help combat bias and microaggression, highlighting the importance of priveledged individuals speaking up for marginalized individuals. This interview took place at the American Society of Clinical Oncology (ASCO) 2022 Annual Meeting in Chicago, IL.

More from Narjust Duma

1:42
Findings from the Sexual Health Assessment in Women with Lung Cancer (SHAWL) study
Narjust Duma • 3 Jun 2022
2:09
Challenges faced by women with lung cancer
Narjust Duma • 3 Jun 2022
1:19
Bias and microaggressions in healthcare
Narjust Duma • 3 Jun 2022
12:28
The Duma Lab: Investigating social justice, gender bias and racial discrimination in medicine
Narjust Duma • 2 Jun 2021

Related Videos

1:56
Phase I trial of trastuzumab deruxtecan and neratinib in HER2-altered tumors
Haeseong Park • 8 Apr 2024
2:45
Remaining challenges in treating solid tumors with CAR-Treg therapy
Leonardo Ferreira • 8 Apr 2024
2:01
Engineering chimeric antigen receptor regulatory T cells for treating cancer
Leonardo Ferreira • 8 Apr 2024
0:59
What challenges are there in using CAR-T cells for solid tumors?
Leonardo Ferreira • 8 Apr 2024
The content of VJOncology is intended for healthcare professionals